Principal Financial Group
PDLI

Principal Financial Group’s PDL BioPharma, Inc. PDLI Stock Holding History

Principal Financial Group’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-12,966
Closed -$38K – 2393
2020
Q2 		$38K Sell
12,966
-102,820
-89% -$325K ﹤0.01% 2293
2020
Q1 		$326K Buy
115,786
+11,597
+11% +$37.4K ﹤0.01% 1944
2019
Q4 		$338K Buy
104,189
+6,745
+7% +$19.6K ﹤0.01% 2030
2019
Q3 		$210K Buy
97,444
+17,841
+22% +$47.7K ﹤0.01% 2135
2019
Q2 		$250K Sell
79,603
-8,612
-10% -$27.9K ﹤0.01% 2105
2019
Q1 		$328K Sell
88,215
-3,437
-4% -$11.6K ﹤0.01% 2017
2018
Q4 		$266K Buy
91,652
+28,434
+45% +$78.1K ﹤0.01% 2057
2018
Q3 		$167K Buy
63,218
+22
+0% +$54 ﹤0.01% 2192
2018
Q2 		$148K Sell
63,196
-11,375
-15% -$31.8K ﹤0.01% 2194
2018
Q1 		$220K Buy
74,571
+4,146
+6% +$11.3K ﹤0.01% 2086
2017
Q4 		$193K Sell
70,425
-32,103
-31% -$98.6K ﹤0.01% 2142
2017
Q3 		$348K Sell
102,528
-4,272
-4% -$11.9K ﹤0.01% 1999
2017
Q2 		$264K Buy
106,800
+50,420
+89% +$116K ﹤0.01% 2078
2017
Q1 		$128K Sell
56,380
-3,534
-6% -$7.82K ﹤0.01% 2128
2016
Q4 		$127K Buy
59,914
+17,356
+41% +$48.4K ﹤0.01% 2137
2016
Q3 		$143K Buy
42,558
+14,256
+50% +$45.3K ﹤0.01% 2074
2016
Q2 		$89K Sell
28,302
-1,176
-4% -$3.92K ﹤0.01% 2095
2016
Q1 		$98K Buy
29,478
+533
+2% +$1.66K ﹤0.01% 2089
2015
Q4 		$102K Buy
28,945
+625
+2% +$2.62K ﹤0.01% 2107
2015
Q3 		$142K Buy
28,320
+211
+0.8% +$1.21K ﹤0.01% 2071
2015
Q2 		$181K Sell
28,109
-1,172
-4% -$7.85K ﹤0.01% 2055
2015
Q1 		$206K Sell
29,281
-131,498
-82% -$952K ﹤0.01% 2020
2014
Q4 		$1.24M Sell
160,779
-164,050
-51% -$1.3M ﹤0.01% 1765
2014
Q3 		$2.43M Buy
324,829
+68,547
+27% +$636K ﹤0.01% 1617
2014
Q2 		$2.48M Sell
256,282
-10,030
-4% -$89.4K ﹤0.01% 1639
2014
Q1 		$2.21M Sell
266,312
-415
-0.2% -$3.56K ﹤0.01% 1634
2013
Q4 		$2.25M Sell
266,727
-785,488
-75% -$6.62M ﹤0.01% 1643
2013
Q3 		$8.39M Buy
1,052,215
+351,789
+50% +$2.83M 0.02% 931
2013
Q2 		$5.41M Buy
+700,426
New +$5.46M 0.01% 1146

Other funds holding PDLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Principal Financial Group's PDLI Position: Q3 2020 in Review

Principal Financial Group sold out of PDL BioPharma, Inc. (PDLI) in Q3 2020, closing a stake of 12,966 shares — an estimated $38K sold.

Principal Financial Group first reported a position in PDLI in Q2 2013 and held it in 29 quarters. The position peaked at $8.39M in Q3 2013. 132 funds tracked by Wall St. Rank hold PDLI as of Q3 2020.

  • Principal Financial Group reported no remaining PDL BioPharma, Inc. position as of Q3 2020 after selling out during the quarter.
  • Principal Financial Group sold 12,966 PDL BioPharma, Inc. shares in Q3 2020, an estimated $38K.
  • Principal Financial Group first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 29 quarters.
  • Principal Financial Group's PDL BioPharma, Inc. position peaked at $8.39M in Q3 2013.
  • 132 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2020.

Based on Principal Financial Group's 13F filing for Q3 2020, filed 6 Nov 2020.